Abstract
Purpose of Review
This review summarizes current state of knowledge of allergic contact dermatitis to corticosteroids and highlights recent findings in this field.
Recent Findings
Tixocortol-21-pivalate and budesonide are the most commonly reported corticosteroid allergens. Up to 50% of those who patch-tested positive to corticosteroids were allergic to more than one compound using European baseline series, though there has been significant variation in rates of positive reactions to multiple corticosteroids in previous studies. Steroid classification, while helpful in predicting steroid allergen cross-reactivity, is not always sufficient. Delayed readings on day 7 should be considered when patch testing to corticosteroids.
Summary
Allergic contact dermatitis to corticosteroids can present a diagnostic challenge due to the anti-inflammatory effects and varied clinical presentation and should be considered in any cutaneous eruption that worsens or fails to improve with appropriately utilized corticosteroids. Corticosteroids are classified based on structure and cross-reactivity patterns. Their allergenicity is influenced by molecular structure and configuration, molecular weight, penetration, and speed of degradation. When a delayed hypersensitivity reaction to a corticosteroid is suspected, appropriate patch testing is required for identification of culprit allergen(s) with subsequent avoidance of the allergen itself, as well as known cross-reactors.
Similar content being viewed by others
Availability of Data and Material
Data sharing not applicable; no new data generated.
Code Availability
Not applicable.
References
Papers of particular interest, published recently, have been highlighted as:
• Of importance
•• Of major importance
Matura M, Goossens A. Contact allergy to corticosteroids. Allergy. 2000;55(8):698–704. https://doi.org/10.1034/j.1398-9995.2000.00121.x.
Baeck M, Marot L, Nicolas JF, Pilette C, Tennstedt D, Goossens A. Allergic hypersensitivity to topical and systemic corticosteroids: a review. Allergy. 2009;64(7):978–94. https://doi.org/10.1111/j.1398-9995.2009.02038.x.
•• Pratt MD, Mufti A, Lipson J, Warshaw EM, Maibach HI, Taylor JS, et al. Patch Test Reactions to Corticosteroids: Retrospective Analysis From the North American Contact Dermatitis Group 2007–2014. Dermatitis: contact, atopic, occupational, drug. 2017;28(1):58–63. https://doi.org/10.1097/der.0000000000000251. A retrospective analysis of 17,978 patients patch tested over 8 years by the North American Contact Dermatitis Group to multiple corticosteroids demonstrated a 4.12% prevalence of corticosteroid allergy, with most frequent culprit allergens being tixocortol-21-pivalate and budesonide. Demonstrated reactivity to only 1 corticosteroid was much more common (70.7%) than multiple sensitivities to corticosteroids and co-reactivity between corticosteroids overlapped between accepted groups.
Baker A, Empson M, The R, Fitzharris P. Skin testing for immediate hypersensitivity to corticosteroids: a case series and literature review. Clinical and experimental allergy: journal of the British Society for Allergy and Clinical Immunology. 2015;45(3):669–76. https://doi.org/10.1111/cea.12441.
Otani IM, Banerji A. Immediate and delayed hypersensitivity reactions to corticosteroids: evaluation and management. Curr Allergy Asthma Rep. 2016;16(3):18. https://doi.org/10.1007/s11882-016-0596-7.
Coopman S, Degreef H, Dooms-Goossens A. Identification of cross-reaction patterns in allergic contact dermatitis from topical corticosteroids. Br J Dermatol. 1989;121(1):27–34. https://doi.org/10.1111/j.1365-2133.1989.tb01396.x.
Baeck M, Goossens A. Immediate and delayed allergic hypersensitivity to corticosteroids: practical guidelines. Contact Dermatitis. 2012;66(1):38–45. https://doi.org/10.1111/j.1600-0536.2011.01967.x.
Baeck M, Chemelle JA, Goossens A, Nicolas JF, Terreux R. Corticosteroid cross-reactivity: clinical and molecular modelling tools. Allergy. 2011;66(10):1367–74. https://doi.org/10.1111/j.1398-9995.2011.02666.x.
Vatti RR, Ali F, Teuber S, Chang C, Gershwin ME. Hypersensitivity reactions to corticosteroids. Clin Rev Allergy Immunol. 2014;47(1):26–37. https://doi.org/10.1007/s12016-013-8365-z.
Hansen J, Bundgaard H. Studies on the stability of corticosteroids V. The degradation pattern of hydrocortisone in aqueous solution. International Journal of Pharmaceutics. 1980;6:307–19.
Wilkinson SM, Jones MF. Corticosteroid usage and binding to arginine: determinants of corticosteroid hypersensitivity. Br J Dermatol. 1996;135(2):225–30.
Dooms-Goossens A, Degreef H. Clinical aspects of contact allergy to corticosteroids. Dermatology (Basel, Switzerland). 1994;189(Suppl 2):54–5. https://doi.org/10.1159/000246992.
Goh CL. Cross-sensitivity to multiple topical corticosteroids. Contact Dermatitis. 1989;20(1):65–7. https://doi.org/10.1111/j.1600-0536.1989.tb03104.x.
Rodríguez-Serna M, Silvestre JF, Quecedo E, Martínez A, Miguel FJ, Gauchía R. Corticosteroid allergy: report of 3 unusually acute cases. Contact Dermatitis. 1996;35(6):361–2. https://doi.org/10.1111/j.1600-0536.1996.tb02417.x.
Dooms-Goossens A. Corticosteroid Contact Allergy: A Challenge to Patch Testing. Dermatitis: contact, atopic, occupational, drug. 1993;4(2):120–2.
Stingeni L, Caraffini S, Assalve D, Lapomarda V, Lisi P. Erythema-multiforme-like contact dermatitis from budesonide. Contact Dermatitis. 1996;34(2):154–5. https://doi.org/10.1111/j.1600-0536.1996.tb02160.x.
Calista D, Schianchi S. Erythema multiforme-like eruption induced by contact dermatitis caused by topical corticosteroids. G Ital Dermatol Venereol. 2008;143(3):227–8.
Miranda-Romero A, Sánchez-Sambucety P, Bajo C, Martinez M, Garcia-Munõz M. Genital oedema from contact allergy to prednicarbate. Contact Dermatitis. 1998;38(4):228–9. https://doi.org/10.1111/j.1600-0536.1998.tb05725.x.
Bennett ML, Fountain JM, McCarty MA, Sherertz EF. Contact allergy to corticosteroids in patients using inhaled or intranasal corticosteroids for allergic rhinitis or asthma. American journal of contact dermatitis: official journal of the American Contact Dermatitis Society. 2001;12(4):193–6. https://doi.org/10.1053/ajcd.2001.28690.
Gonzalo Garijo MA, Bobadilla GP. Cutaneous-mucosal allergic contact reaction due to topical corticosteroids. Allergy. 1995;50(10):833–6. https://doi.org/10.1111/j.1398-9995.1995.tb05058.x.
Bircher AJ, Pelloni F, Langauer Messmer S, Müller D. Delayed hypersensitivity reactions to corticosteroids applied to mucous membranes. Br J Dermatol. 1996;135(2):310–3.
Isaksson M, Bruze M, Hörnblad Y, Svenonius E, Wihl JA. Contact allergy to corticosteroids in asthma/rhinitis patients. Contact Dermatitis. 1999;40(6):327–8. https://doi.org/10.1111/j.1600-0536.1999.tb06086.x.
Isaksson M, Bruze M, Wihl JA. Contact allergy to budesonide and perforation of the nasal septum. Contact Dermatitis. 1997;37(3):133. https://doi.org/10.1111/j.1600-0536.1997.tb00324.x.
Pirker C, Misić A, Frosch PJ. Angioedema and dysphagia caused by contact allergy to inhaled budesonide. Contact Dermatitis. 2003;49(2):77–9. https://doi.org/10.1111/j.0105-1873.2003.00169.x.
Laberge L, Pratt M. Immediate and delayed hypersensitivity to systemic corticosteroids: 2 case reports. Dermatitis: contact, atopic, occupational, drug. 2012;23(6):288–90. https://doi.org/10.1097/DER.0b013e318277ca22.
• Labadie EA, Houle MC. Nonmedicinal Ingredients in Topical Corticosteroids Available in Canada. J Cutan Med Surg. 2020;24(1):60–3. https://doi.org/10.1177/1203475419887729. A review of the available topical corticosteroids in Canada and the percentage of those with potentially allergenic ingredients.
Dooms-Goossens A, Andersen KE, Brandäo FM, Bruynzeel D, Burrows D, Camarasa J, et al. Corticosteroid contact allergy: an EECDRG multicentre study. Contact Dermatitis. 1996;35(1):40–4. https://doi.org/10.1111/j.1600-0536.1996.tb02264.x.
Kot M, Bogaczewicz J, Kręcisz B, Woźniacka A. Contact allergy in the population of patients with chronic inflammatory dermatoses and contact hypersensitivity to corticosteroids. Postepy dermatologii i alergologii. 2017;34(3):253–9. https://doi.org/10.5114/ada.2017.67848.
Isaksson M, Brandão FM, Bruze M, Goossens A. Recommendation to include budesonide and tixocortol pivalate in the European standard series. ESCD and EECDRG. European Society of Contact Dermatitis. Contact dermatitis. 2000;43(1):41–2. https://doi.org/10.1034/j.1600-0536.2000.043001041.x.
Chowdhury MM, Statham BN, Sansom JE, Foulds IS, English JS, Podmore P, et al. Patch testing for corticosteroid allergy with low and high concentrations of tixocortol pivalate and budesonide. Contact Dermatitis. 2002;46(5):311–2. https://doi.org/10.1034/j.1600-0536.2002.460519.x.
Lauerma AI. Screening for corticosteroid contact sensitivity. Comparison of tixocortol pivalate, hydrocortisone-17-butyrate and hydrocortisone. Contact dermatitis. 1991;24(2):123–30. https://doi.org/10.1111/j.1600-0536.1991.tb01664.x.
Boffa MJ, Wilkinson SM, Beck MH. Screening for corticosteroid contact hypersensitivity. Contact Dermatitis. 1995;33(3):149–51. https://doi.org/10.1111/j.1600-0536.1995.tb00535.x.
Vind-Kezunovic D, Johansen JD, Carlsen BC. Prevalence of and factors influencing sensitization to corticosteroids in a Danish patch test population. Contact Dermatitis. 2011;64(6):325–9. https://doi.org/10.1111/j.1600-0536.2011.01898.x.
•• Mercader-García P, Pastor-Nieto MA, García-Doval I, Giménez-Arnau A, González-Pérez R, Fernández-Redondo V, et al. Are the Spanish baseline series markers sufficient to detect contact allergy to corticosteroids in Spain? A GEIDAC prospective study Contact dermatitis. 2018;78(1):76–82. https://doi.org/10.1111/cod.12874. In this retrospective study, the authors demonstrated that patch testing based on Baeck classification system may not be sufficient to detect all possible allergic reactions to corticosteroids.
DeKoven J, Silverberg J, Warshaw Erin, Atwater A, Reeder M, Sasseville Denis, Taylor J, Zug K, Belsito D, Maibach H, Pratt M, Mathias C, DeLeo V, Fowler J. North American Contact Dermatitis Group Patch Test Results: 2017–2018. Dermatitis. 2021;32(2):111–123. https://doi.org/10.1097/DER.0000000000000729
Baeck M, Goossens A. Patients with airborne sensitization/contact dermatitis from budesonide-containing aerosols “by proxy.” Contact Dermatitis. 2009;61(1):1–8. https://doi.org/10.1111/j.1600-0536.2009.01575.x (PMID: 19659959).
Tran JM, Reeder MJ. When the treatment is the culprit: prevalence of allergens in prescription topical steroids and immunomodulators. J Am Acad Dermatol. 2020;83(1):228–30. https://doi.org/10.1016/j.jaad.2019.11.020.
Baeck M, Chemelle JA, Terreux R, Drieghe J, Goossens A. Delayed hypersensitivity to corticosteroids in a series of 315 patients: clinical data and patch test results. Contact Dermatitis. 2009;61(3):163–75. https://doi.org/10.1111/j.1600-0536.2009.01602.
•• van Amerongen CCA, Ofenloch R, Dittmar D, Schuttelaar MLA. New positive patch test reactions on day 7-The additional value of the day 7 patch test reading. Contact Dermatitis. 2019;81(4):280–7. https://doi.org/10.1111/cod.13322. This study showed that a delayed (day 7) reading may be of value in identifying contact allergy to corticosteroids.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing Interests
The authors declare no competing interests.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
This article is part of the Topical Collection on Contact Dermatitis
Rights and permissions
About this article
Cite this article
Spurr, A., Pratt, M. & Shahrigharahkoshan, S. Allergic Contact Dermatitis to Corticosteroids. Curr Derm Rep 10, 140–147 (2021). https://doi.org/10.1007/s13671-021-00338-1
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13671-021-00338-1